C
KRYS icon

Covestor’s Krystal Biotech KRYS Stock Holding History

Covestor’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
493
+193
+64% +$57.7K 0.11% 147
2026
Q1 		$78K Sell
300
-941
-76% -$250K 0.05% 410
2025
Q4 		$306K Sell
1,241
-537
-30% -$113K 0.16% 98
2025
Q3 		$314K Buy
1,778
+405
+29% +$60.6K 0.17% 72
2025
Q2 		$189K Sell
1,373
-124
-8% -$18.2K 0.11% 212
2025
Q1 		$270K Buy
1,497
+789
+111% +$133K 0.18% 66
2024
Q4 		$111K Buy
708
+642
+973% +$114K 0.07% 462
2024
Q3 		$12K Hold
66
– – 0.01% 1442
2024
Q2 		$12K Sell
66
-529
-89% -$88.8K 0.01% 1415
2024
Q1 		$106K Buy
595
+2
+0.3% +$278 0.07% 507
2023
Q4 		$74K Buy
593
+45
+8% +$4.99K 0.05% 674
2023
Q3 		$64K Sell
548
-178
-25% -$21.7K 0.05% 652
2023
Q2 		$85K Buy
726
+724
+36,200% +$73.9K 0.06% 534
2023
Q1 		$0 Hold
2
– – ﹤0.01% 2312
2022
Q4 		$0 Hold
2
– – ﹤0.01% 2337
2022
Q3 		$0 Sell
2
-2
-50% -$144 ﹤0.01% 2304
2022
Q2 		$0 Sell
4
-1
-20% -$62 ﹤0.01% 2143
2022
Q1 		$0 Sell
5
-1
-17% -$62 ﹤0.01% 2279
2021
Q4 		$0 Buy
+6
New +$349 ﹤0.01% 2209

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Covestor's KRYS Position: Q2 2026 in Review

Covestor increased its Krystal Biotech (KRYS) stake by 64% in Q2 2026, buying an estimated $57.7K and bringing the position to 493 shares worth $183K. The position accounts for 0.11% of the portfolio, ranked #147.

Covestor first reported a position in KRYS in Q4 2021 and has held it in 19 quarters since. The position peaked at $314K in Q3 2025. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Covestor held 493 shares of Krystal Biotech worth $183K as of Q2 2026.
  • Covestor bought 193 Krystal Biotech shares in Q2 2026, an estimated $57.7K.
  • Krystal Biotech made up 0.11% of Covestor's portfolio in Q2 2026, its #147 holding.
  • Covestor first reported a position in Krystal Biotech in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Krystal Biotech position peaked at $314K in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.